Open label, flexible dose 12-week clinical trial of the safety and efficacy of acamprosate in the treatment of pathological gambling
Phase of Trial: Phase IV
Latest Information Update: 31 May 2017
At a glance
- Drugs Acamprosate (Primary)
- Indications Gambling
- Focus Therapeutic Use
- 07 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Dec 2007 New trial record.